Ferrocene-Based Hybrid Drugs as Potential Anticancer and Antibacterial Therapeutic Agents for Incorporation into Nanocarriers: In Silico, In Vitro, Molecular Docking Evaluations.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 6, p. 722, doi. 10.3390/pharmaceutics17060722
- By:
- Publication type:
- Article